T
Theresa Nguyen
Researcher at University of Texas MD Anderson Cancer Center
Publications - 18
Citations - 746
Theresa Nguyen is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Cell culture. The author has an hindex of 10, co-authored 15 publications receiving 644 citations. Previous affiliations of Theresa Nguyen include University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Epithelioid Sarcoma and Unclassified Sarcoma with Epithelioid Features: Clinicopathological Variables, Molecular Markers, and a New Experimental Model
Aniket Sakharpe,Guy Lahat,Taher Gulamhusein,Ping Liu,Svetlana Bolshakov,Theresa Nguyen,Pingyu Zhang,Roman Belousov,Eric D. Young,Xianbiao Xie,Priya Rao,Jason L. Hornick,Alexander J. Lazar,Raphael E. Pollock,Dina Lev +14 more
TL;DR: Enhanced knowledge of ES and USEF clinical behavior, marker expression, and molecular determinants, extended via experimental models, will hopefully accelerate development of urgently needed effective targeted therapies for ES andUSEF.
Journal ArticleDOI
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target
Zeming Jin,Guy Lahat,Borys Korchin,Theresa Nguyen,Quansheng Zhu,Xuemei Wang,Alexander J. Lazar,Jonathan C. Trent,Raphael E. Pollock,Dina Lev +9 more
TL;DR: MK enhances STS tumor growth; the results support further investigation of MK and its receptors as therapeutic targets for human STS.
Journal ArticleDOI
Combined vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft tissue sarcoma
Wenhong Ren,Borys Korchin,Guy Lahat,Caimiao Wei,Svetlana Bolshakov,Theresa Nguyen,William Merritt,Adam P. Dicker,Alexander J. Lazar,Anil K. Sood,Raphael E. Pollock,Dina Lev +11 more
TL;DR: Vandetanib has antitumor effects against human STS subtypes in vitro and in vivo, where it also affects the tumor-associated microenvironment, and clinical trials evaluating vandenib, perhaps with low-dose chemotherapy, seem warranted.
Journal ArticleDOI
Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
Marieke A. de Graaff,Jamie S.E. Yu,Hannah C. Beird,Davis R. Ingram,Theresa Nguyen,Jeffrey Juehui Liu,Svetlana Bolshakov,Karoly Szuhai,Pierre Åman,Keila E. Torres,Dina Lev,Torsten O. Nielsen,Judith V.M.G. Bovée,Alexander J. Lazar,Neeta Somaiah +14 more
TL;DR: The established DL-221 cell line is the only published available myxoid liposarcoma cell line that underwent spontaneous immortalization, without requiring SV40 transformation, and its xenograft model are unique and helpful tools to study the biology and novel potential-targeted treatment approaches.
Journal ArticleDOI
Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.
Courtney Pollard,Theresa Nguyen,Sweet Ping Ng,Steven J. Frank,Adam S. Garden,Gary Brandon Gunn,Clifton D. Fuller,Beth M. Beadle,William H. Morrison,Shah J. Shah,He Wang,Sam Tung,Conjun Wang,Lawrence D. Ginsberg,Mark Zafereo,Erich M. Sturgis,Shirley Y. Su,Ehab Y. Hanna,David I. Rosenthal,Jack Phan +19 more
TL;DR: The purpose of this study was to present the experience with retropharyngeal node reirradiation using highly conformal radiotherapy (RT), and to describe the benefits and challenges of this treatment.